Isabel Leroux-Roels

14PUBLICATIONS
45CO-AUTHORS
Environmental epidemiologyAdolescent healthPreventative health careHorticultural crop protection (incl. pests, diseases and weeds)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 26, 2026
Correction: Leroux-Roels et al. Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines 2026, 14, 146.

|Jun 04, 2026
Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥50 years: a phase 3, randomized, non-inferiority trial.

|Apr 17, 2026
Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: a randomized, non-inferiority trial.

|Mar 09, 2026
Induction of a Th1-Type Polyfunctional T-Cell Response by the Four-segmented Rift Valley Fever Candidate Vaccine in Humans.

Amare Aregay, Julia Friese, Sharon Porrez

|Mar 03, 2026
A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults.

Ilse De Coster, Isabel Leroux-Roels, Kanchanamala Withanage

|Feb 26, 2026
Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.

Isabel Leroux-Roels, Tracey A Day, Sofie Deleu

Pageof 3

Frequent Collaborators

3 joint publications

Bart Jacobs

3 joint publications

Gwenn Waerlop

2 joint publications

Jan J De Waele

2 joint publications

Vicky Cárdenas